Free Trial

Equifax (EFX) Financials

Equifax logo
$231.31 +0.67 (+0.29%)
Closing price 10/23/2025 03:59 PM Eastern
Extended Trading
$231.72 +0.41 (+0.18%)
As of 04:00 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Annual Income Statements for Equifax

Annual Income Statements for Equifax

This table shows Equifax's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Period end date 12/31/2014 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Net Income / (Loss) Attributable to Common Shareholders
367 429 489 587 311 -384 520 744 696 545 604
Consolidated Net Income / (Loss)
374 435 495 598 317 -378 526 749 700 552 607
Net Income / (Loss) Continuing Operations
374 435 495 598 317 -378 526 749 700 552 607
Total Pre-Tax Income
574 637 728 747 370 -414 685 949 930 718 811
Total Revenue
2,368 2,600 -92 3,269 3,309 3,396 -142 4,778 4,939 5,024 5,452
Net Interest Income / (Expense)
-69 -64 -92 -93 -104 -112 -142 -146 -183 -241 -229
Total Interest Income
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Interest Expense
69 64 92 93 104 112 142 146 183 241 229
Long-Term Debt Interest Expense
69 64 92 93 104 112 142 146 183 241 229
Total Non-Interest Income
2,436 2,664 0.00 3,362 3,412 3,508 0.00 4,924 5,122 5,265 5,681
Other Non-Interest Income
- 2,664 - 3,362 3,412 3,508 - 4,924 5,122 5,265 5,681
Total Non-Interest Expense
1,798 1,970 -820 2,531 2,964 3,843 -827 3,786 4,066 4,332 4,639
Property & Liability Insurance Claims
- - - 1,211 - 1,522 - 1,981 2,177 2,335 2,519
Other Operating Expenses
1,596 1,772 2,054 1,032 2,654 1,990 3,060 1,325 1,329 1,386 1,451
Depreciation Expense
202 198 265 288 310 331 391 480 560 611 670
Nonoperating Income / (Expense), net
4.60 6.50 - 7.70 26 33 - -43 57 26 -2.50
Income Tax Expense
200 202 233 149 53 -36 159 201 230 166 203
Net Income / (Loss) Attributable to Noncontrolling Interest
6.60 5.70 6.30 11 6.50 6.00 6.10 4.30 4.00 6.40 3.20
Basic Earnings per Share
$3.03 $3.61 $4.10 $4.89 $2.58 ($3.18) $4.28 $6.11 $5.69 $4.44 $4.88
Weighted Average Basic Shares Outstanding
121.20M 118.70M 119.30M 120.10M 120.40M 120.90M 121.50M 121.90M 122.40M 122.90M 123.80M
Diluted Earnings per Share
$2.97 $3.55 $4.04 $4.83 $2.56 ($3.15) $4.24 $6.02 $5.65 $4.40 $4.84
Weighted Average Diluted Shares Outstanding
123.50M 120.90M 121.10M 121.50M 121.40M 122M 122.80M 123.60M 123.30M 123.90M 124.90M
Weighted Average Basic & Diluted Shares Outstanding
121.30M 118.90M 119.20M 120.10M 120.40M 120.80M 121.79M 122.08M 122.49M 123.96M 124.02M
Cash Dividends to Common per Share
$1.00 $1.16 $1.32 $1.56 $1.56 $1.56 $1.56 $1.56 $1.56 $1.56 $1.56

Quarterly Income Statements for Equifax

This table shows Equifax's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025
Period end date 3/31/2023 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025
Net Income / (Loss) Attributable to Common Shareholders
112 138 162 132 125 164 141 174 133 191 160
Consolidated Net Income / (Loss)
114 139 164 135 126 165 143 173 134 193 162
Net Income / (Loss) Continuing Operations
114 139 164 135 126 165 143 173 134 193 162
Total Pre-Tax Income
152 192 191 183 167 225 194 226 185 261 215
Total Revenue
1,244 1,257 1,256 1,266 1,330 1,373 1,386 1,364 1,389 1,484 1,493
Net Interest Income / (Expense)
-58 -61 -63 -60 -60 -57 -56 -56 -53 -53 -52
Total Interest Income
0.00 0.00 0.00 - 0.00 0.00 0.00 - 0.00 0.00 0.00
Total Interest Expense
58 61 63 60 60 57 56 56 53 53 52
Long-Term Debt Interest Expense
58 61 63 60 60 57 56 56 53 53 52
Total Non-Interest Income
1,302 1,318 1,319 1,327 1,389 1,431 1,442 1,419 1,442 1,537 1,545
Other Non-Interest Income
1,302 1,318 1,319 1,327 1,389 1,431 1,442 1,419 1,442 1,537 1,545
Total Non-Interest Expense
1,097 1,081 1,073 1,082 1,165 1,148 1,195 1,131 1,206 1,226 1,281
Property & Liability Insurance Claims
580 - 585 - 628 631 645 - 657 665 663
Other Operating Expenses
366 931 333 -245 373 353 380 -286 375 384 434
Depreciation Expense
150 150 154 157 164 165 169 172 175 177 183
Nonoperating Income / (Expense), net
4.40 16 7.10 -1.70 1.60 -0.30 3.00 -6.80 2.50 3.60 3.20
Income Tax Expense
39 53 26 48 41 59 51 52 52 69 54
Net Income / (Loss) Attributable to Noncontrolling Interest
1.10 1.10 2.10 2.10 1.20 1.30 1.40 -0.70 0.70 1.30 1.30
Basic Earnings per Share
$0.92 $1.13 $1.32 $1.07 $1.01 $1.32 $1.14 $1.41 $1.07 $1.54 $1.30
Weighted Average Basic Shares Outstanding
122.60M 122.70M 123M 122.90M 123.50M 123.70M 123.90M 123.80M 124.10M 124M 123.10M
Diluted Earnings per Share
$0.91 $1.12 $1.31 $1.06 $1.00 $1.31 $1.13 $1.40 $1.06 $1.53 $1.29
Weighted Average Diluted Shares Outstanding
123.50M 123.80M 123.90M 123.90M 124.80M 124.80M 125.20M 124.90M 125.10M 125M 124.10M
Weighted Average Basic & Diluted Shares Outstanding
122.64M 122.72M 123.22M 123.96M 123.61M 123.74M 123.95M 124.02M 124.20M 123.80M 122.39M
Cash Dividends to Common per Share
$0.39 $0.39 $0.39 $0.39 $0.39 $0.39 $0.39 $0.39 $0.39 $0.50 $0.50

Annual Cash Flow Statements for Equifax

This table details how cash moves in and out of Equifax's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Period end date 12/31/2014 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Net Change in Cash & Equivalents
-108 -35 36 207 -113 178 1,283 -1,460 61 -68 -47
Net Cash From Operating Activities
616 769 823 816 672 314 946 1,335 757 1,117 1,325
Net Cash From Continuing Operating Activities
616 769 823 816 672 314 946 1,335 757 1,123 1,325
Net Income / (Loss) Continuing Operations
374 435 495 598 317 -378 526 749 700 552 607
Consolidated Net Income / (Loss)
374 435 495 598 317 -378 526 749 700 552 607
Depreciation Expense
204 200 269 291 316 337 399 490 569 620 681
Non-Cash Adjustments to Reconcile Net Income
11 -5.50 -12 -5.80 43 -33 -28 123 114 -12 15
Changes in Operating Assets and Liabilities, net
27 140 71 -67 -3.20 388 49 -26 -626 -36 22
Net Cash From Investing Activities
-429 -148 -1,976 -350 -462 -698 -493 -3,398 -960 -878 -512
Net Cash From Continuing Investing Activities
-427 -148 -1,976 -350 -462 -698 -493 -3,398 -960 -878 -512
Purchase of Investment Securities
-427 -151 -1,976 -358 -6.90 -698 -493 -3,405 -1,058 -284 -512
Divestitures
0.60 2.90 - - - 0.00 0.00 1.50 99 6.90 0.00
Net Cash From Financing Activities
-283 -639 1,160 -264 -311 558 811 618 274 -306 -846
Net Cash From Continuing Financing Activities
-283 -639 1,160 -264 -311 558 811 618 274 -306 -846
Issuance of Debt
380 0.00 1,575 352 995 998 1,123 1,697 992 873 650
Repayment of Debt
-290 -336 -283 -323 -1,067 -257 -136 -791 -506 -957 -1,360
Payment of Dividends
-129 -144 -163 -196 -198 -195 -194 -197 -194 -237 -198
Other Financing Activities, Net
57 37 32 -20 -40 12 17 -22 -17 15 61
Effect of Exchange Rate Changes
-11 -17 29 4.30 -13 3.50 19 -14 -11 -0.80 -14

Quarterly Cash Flow Statements for Equifax

This table details how cash moves in and out of Equifax's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025
Period end date 3/31/2023 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025
Net Cash From Operating Activities
151 262 382 322 253 268 480 325 224 361 560
Net Cash From Continuing Operating Activities
151 262 382 328 253 268 480 325 224 361 560
Net Income / (Loss) Continuing Operations
114 139 164 135 126 165 143 173 134 193 162
Consolidated Net Income / (Loss)
114 139 164 135 126 165 143 173 134 193 162
Depreciation Expense
152 152 157 159 167 167 173 174 176 179 185
Non-Cash Adjustments to Reconcile Net Income
25 8.30 -53 8.20 23 -2.60 6.00 -12 31 8.00 54
Changes in Operating Assets and Liabilities, net
-140 -38 114 27 -63 -62 157 -10 -117 -19 159
Net Cash From Investing Activities
-163 -156 -406 -154 -132 -137 -124 -119 -107 -121 -122
Net Cash From Continuing Investing Activities
-163 -156 -406 -154 -132 -137 -124 -119 -107 -121 -122
Purchase of Investment Securities
-163 -163 -406 448 -132 -137 -124 -119 -107 -122 -122
Net Cash From Financing Activities
-43 -174 281 -370 -132 -149 -64 -501 -96 -251 -437
Net Cash From Continuing Financing Activities
-43 -174 281 -370 -132 -149 -64 -501 -96 -251 -437
Repayment of Debt
-161 -831 327 -292 -88 -115 -694 -463 -48 -68 -88
Repurchase of Common Equity
- - - - - - - - - - -300
Payment of Dividends
-48 -50 -49 -91 -49 -51 -49 -49 -49 -66 -64
Other Financing Activities, Net
-9.30 8.90 2.10 13 4.50 18 29 10 0.80 10 13
Effect of Exchange Rate Changes
2.30 -0.50 -7.90 5.30 -4.70 -1.10 -4.90 -2.80 4.40 5.10 -1.20

Annual Balance Sheets for Equifax

This table presents Equifax's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Period end date 12/31/2014 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Total Assets
4,661 4,502 6,664 7,233 7,153 7,909 9,612 11,041 11,548 12,280 11,759
Cash and Due from Banks
128 93 129 336 224 401 1,685 225 285 217 170
Loans and Leases, Net of Allowance
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Premises and Equipment, Net
43 154 160 139 81 948 -235 1,316 1,587 1,834 -926
Goodwill
2,607 2,571 3,974 4,184 4,130 4,308 4,496 6,258 6,384 6,830 6,548
Intangible Assets
1,306 1,135 1,726 1,770 1,878 1,140 2,467 1,993 1,913 1,954 4,433
Other Assets
576 548 675 804 841 1,112 1,199 1,249 1,379 1,446 1,534
Total Liabilities & Shareholders' Equity
4,661 4,502 6,664 7,233 7,153 7,909 9,612 11,041 11,548 12,280 11,759
Total Liabilities
2,426 2,151 3,943 3,994 3,998 5,286 6,402 7,440 7,575 7,593 6,840
Short-Term Debt
401 90 666 1,076 181 151 1,260 1,036 1,218 1,161 826
Accrued Interest Payable
86 113 149 161 213 164 252 238 229 245 251
Other Short-Term Payables
337 401 444 329 433 1,044 971 1,017 568 613 735
Long-Term Debt
1,146 1,138 2,087 1,739 2,631 3,380 3,277 4,470 4,820 4,748 4,323
Other Long-Term Liabilities
458 409 596 690 540 548 641 678 739 826 706
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Redeemable Noncontrolling Interest
- - - - - - - - 0.00 135 105
Total Equity & Noncontrolling Interests
2,235 2,350 2,721 3,239 3,156 2,623 3,210 3,601 3,973 4,552 4,814
Total Preferred & Common Equity
2,200 2,311 2,663 3,174 3,108 2,579 3,168 3,584 3,957 4,534 4,797
Preferred Stock
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity
2,200 2,311 2,663 3,174 3,108 2,579 3,168 3,584 3,957 4,534 4,797
Common Stock
1,432 1,491 1,544 1,563 1,587 1,636 1,701 1,767 1,825 1,992 2,146
Retained Earnings
3,555 3,834 4,153 4,601 4,718 3,855 4,185 4,752 5,256 5,609 6,019
Treasury Stock
-2,352 -2,530 -2,506 -2,578 -2,571 -2,557 -2,547 -2,639 -2,651 -2,635 -2,645
Accumulated Other Comprehensive Income / (Loss)
-435 -485 -529 -412 -626 -354 -171 -295 -474 -431 -723
Noncontrolling Interest
35 40 59 65 48 44 42 17 17 18 18

Quarterly Balance Sheets for Equifax

This table presents Equifax's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025
Period end date 3/31/2023 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025
Total Assets
11,584 11,538 12,349 12,280 12,251 12,152 12,344 11,759 11,855 11,918 11,832
Cash and Due from Banks
233 164 413 217 201 182 468 170 195 189 189
Loans and Leases, Net of Allowance
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Premises and Equipment, Net
-570 -629 -665 1,834 -746 -813 -874 1,892 -974 -1,017 -1,087
Goodwill
6,396 6,401 6,731 6,830 6,761 6,747 6,730 6,548 6,591 6,655 6,665
Intangible Assets
4,080 4,145 4,427 1,954 4,464 4,483 4,517 1,616 4,432 4,450 4,467
Other Assets
1,446 1,457 1,443 1,446 1,571 1,554 1,503 1,534 1,611 1,641 1,598
Total Liabilities & Shareholders' Equity
11,584 11,538 12,349 12,280 12,251 12,152 12,344 11,759 11,855 11,918 11,832
Total Liabilities
7,502 7,330 7,864 7,593 7,539 7,319 7,298 6,840 6,742 6,682 6,756
Short-Term Debt
962 317 692 1,161 1,078 972 903 826 812 1,019 916
Accrued Interest Payable
283 271 267 245 306 238 263 251 281 270 299
Other Short-Term Payables
548 504 623 613 590 577 708 735 638 657 769
Long-Term Debt
4,988 5,503 5,500 4,748 4,745 4,743 4,721 4,323 4,324 4,051 4,054
Other Long-Term Liabilities
722 734 782 826 820 789 702 706 687 686 719
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Redeemable Noncontrolling Interest
- - 176 135 132 121 121 105 113 116 119
Total Equity & Noncontrolling Interests
4,082 4,208 4,309 4,552 4,581 4,713 4,926 4,814 5,000 5,120 4,957
Total Preferred & Common Equity
4,064 4,191 4,293 4,534 4,562 4,696 4,909 4,797 4,981 5,104 4,939
Preferred Stock
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity
4,064 4,191 4,293 4,534 4,562 4,696 4,909 4,797 4,981 5,104 4,939
Common Stock
1,862 1,881 1,967 1,992 2,055 2,088 2,128 2,146 2,184 2,206 2,234
Retained Earnings
5,320 5,411 5,525 5,609 5,685 5,800 5,893 6,019 6,103 6,232 6,330
Treasury Stock
-2,657 -2,655 -2,635 -2,635 -2,652 -2,648 -2,647 -2,645 -2,648 -2,775 -3,074
Accumulated Other Comprehensive Income / (Loss)
-461 -446 -564 -431 -527 -544 -465 -723 -657 -560 -551
Noncontrolling Interest
18 17 16 18 19 17 17 18 19 16 19

Annual Metrics And Ratios for Equifax

This table displays calculated financial ratios and metrics derived from Equifax's official financial filings.

Metric 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Period end date 12/31/2014 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Growth Metrics
- - - - - - - - - - -
Revenue Growth
6.00% 9.80% -103.54% 3,649.84% 1.20% 2.64% -104.17% 3,474.51% 3.37% 1.71% 8.52%
EBITDA Growth
7.37% 7.28% 20.09% 3.30% -35.87% -116.63% 1,087.70% 36.65% -2.73% -8.99% 13.84%
EBIT Growth
7.39% 10.62% 15.57% 1.47% -53.38% -229.78% 253.25% 44.83% -12.03% -20.71% 17.45%
NOPAT Growth
8.64% 16.00% 15.04% 19.54% -50.18% -206.15% 268.13% 48.72% -15.98% -19.09% 14.52%
Net Income Growth
3.92% 16.26% 13.87% 20.78% -46.99% -219.27% 239.17% 42.25% -6.45% -21.21% 10.08%
EPS Growth
4.58% 19.53% 13.80% 19.55% -47.00% -223.05% 234.60% 41.98% -6.15% -22.12% 10.00%
Operating Cash Flow Growth
8.30% 24.81% 7.01% -0.85% -17.62% -53.32% 201.53% 41.07% -43.28% 47.51% 18.60%
Free Cash Flow Firm Growth
54.93% 61.02% -321.40% 100.91% 2,896.52% -231.02% -113.62% 45.93% 57.36% 78.49% 2,247.63%
Invested Capital Growth
-0.58% -5.35% 52.97% 10.58% -1.43% 3.13% 25.90% 17.55% 9.92% 5.84% -4.98%
Revenue Q/Q Growth
2.01% 1.67% -103.15% 303.60% -33.92% 2.03% -103.75% 822.99% -1.42% 2.51% 1.82%
EBITDA Q/Q Growth
4.06% 1.59% 4.75% -1.14% -17.89% 5.18% 34.92% -2.53% -5.41% 6.27% 4.37%
EBIT Q/Q Growth
4.57% 2.34% 3.04% -1.70% -30.38% -0.43% 63.10% -6.51% -9.55% 10.03% 6.23%
NOPAT Q/Q Growth
4.77% 2.32% 2.44% 7.94% -33.90% -0.43% 67.54% 11.30% -11.63% 8.67% 7.52%
Net Income Q/Q Growth
5.62% 3.38% 2.44% 9.06% -30.18% -3.28% 11.01% 6.46% -1.96% 4.83% 6.83%
EPS Q/Q Growth
6.45% 3.50% 2.54% 9.03% -30.43% -2.94% 10.42% 6.55% -1.74% 4.27% 7.56%
Operating Cash Flow Q/Q Growth
1.80% 3.99% 5.99% -8.06% -5.95% 26.58% 7.56% 7.07% -7.33% -0.29% 0.20%
Free Cash Flow Firm Q/Q Growth
671.91% -14.24% 9.60% -95.28% -1.45% -150.89% 17.12% 42.88% -287.90% 85.15% 98.71%
Invested Capital Q/Q Growth
-4.54% -1.78% -3.56% 1.66% -0.78% 4.28% 3.25% -1.19% 1.84% -0.75% -5.65%
Profitability Metrics
- - - - - - - - - - -
EBITDA Margin
32.68% 31.93% 0.00% 31.50% 19.96% -3.23% 0.00% 31.02% 29.19% 26.12% 27.40%
EBIT Margin
24.06% 24.24% 0.00% 22.60% 10.41% -13.17% 0.00% 20.77% 17.67% 13.78% 14.91%
Profit (Net Income) Margin
15.80% 16.72% 0.00% 18.29% 9.58% -11.13% 0.00% 15.66% 14.18% 10.98% 11.14%
Tax Burden Percent
65.13% 68.30% 67.99% 80.10% 85.58% 91.37% 76.80% 78.86% 75.31% 76.85% 74.93%
Interest Burden Percent
100.81% 101.03% 100.00% 101.04% 107.52% 92.55% 100.00% 95.65% 106.49% 103.71% 99.69%
Effective Tax Rate
34.87% 31.70% 32.01% 19.90% 14.42% 0.00% 23.20% 21.14% 24.69% 23.15% 25.07%
Return on Invested Capital (ROIC)
9.78% 11.70% 0.00% 10.27% 4.91% -5.16% 0.00% 9.29% 6.88% 5.16% 5.90%
ROIC Less NNEP Spread (ROIC-NNEP)
9.98% 12.02% 0.00% 10.49% 5.69% -7.22% 0.00% 8.61% 7.62% 5.49% 5.86%
Return on Net Nonoperating Assets (RNNOA)
6.56% 7.27% 0.00% 9.80% 5.01% -7.92% 0.00% 12.69% 11.61% 7.58% 6.75%
Return on Equity (ROE)
16.35% 18.97% 19.52% 20.07% 9.91% -13.09% 18.04% 21.98% 18.49% 12.74% 12.64%
Cash Return on Invested Capital (CROIC)
10.36% 17.19% -30.94% 0.22% 6.35% -8.25% -15.36% -6.85% -2.58% -0.51% 11.01%
Operating Return on Assets (OROA)
12.38% 13.75% 0.00% 10.63% 4.79% -5.94% 0.00% 9.61% 7.73% 5.81% 6.76%
Return on Assets (ROA)
8.13% 9.49% 0.00% 8.61% 4.41% -5.02% 0.00% 7.25% 6.20% 4.63% 5.05%
Return on Common Equity (ROCE)
16.08% 18.66% 19.15% 19.65% 9.74% -12.88% 17.77% 21.79% 18.41% 12.49% 12.28%
Return on Equity Simple (ROE_SIMPLE)
17.00% 18.82% 18.59% 18.84% 10.20% -14.66% 16.61% 20.88% 17.70% 12.17% 12.66%
Net Operating Profit after Tax (NOPAT)
371 430 495 592 295 -313 526 783 657 532 609
NOPAT Margin
15.67% 16.55% 0.00% 18.10% 8.91% -9.22% 0.00% 16.38% 13.31% 10.59% 11.17%
Net Nonoperating Expense Percent (NNEP)
-0.20% -0.32% 0.00% -0.22% -0.79% 2.05% 0.00% 0.68% -0.74% -0.33% 0.03%
SG&A Expenses to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
75.94% 75.76% 0.00% 77.40% 89.59% 113.17% 0.00% 79.23% 82.33% 86.22% 85.09%
Earnings before Interest and Taxes (EBIT)
570 630 728 739 345 -447 685 992 873 692 813
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
774 830 997 1,030 660 -110 1,085 1,482 1,442 1,312 1,494
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
4.03 5.25 4.94 4.20 3.45 6.35 7.22 9.78 5.93 6.68 6.59
Price to Tangible Book Value (P/TBV)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Price to Revenue (P/Rev)
3.74 4.67 0.00 4.08 3.24 4.82 0.00 7.34 4.75 6.03 5.79
Price to Earnings (P/E)
24.13 28.28 26.94 22.69 34.50 0.00 43.98 47.12 33.73 55.55 52.29
Dividend Yield
1.36% 1.13% 1.20% 1.41% 1.76% 1.15% 0.83% 0.54% 0.81% 0.63% 0.61%
Earnings Yield
4.14% 3.54% 3.71% 4.41% 2.90% 0.00% 2.27% 2.12% 2.96% 1.80% 1.91%
Enterprise Value to Invested Capital (EV/IC)
2.73 3.72 2.90 2.62 2.24 3.18 3.33 4.43 2.92 3.41 3.64
Enterprise Value to Revenue (EV/Rev)
4.36 5.12 0.00 4.85 4.03 5.76 0.00 8.45 5.92 7.19 6.73
Enterprise Value to EBITDA (EV/EBITDA)
13.33 16.03 15.90 15.41 20.21 0.00 23.76 27.24 20.29 27.54 24.57
Enterprise Value to EBIT (EV/EBIT)
18.12 21.12 21.76 21.48 38.74 0.00 37.61 40.68 33.51 52.20 45.13
Enterprise Value to NOPAT (EV/NOPAT)
27.81 30.92 32.01 26.81 45.27 0.00 48.98 51.58 44.49 67.93 60.23
Enterprise Value to Operating Cash Flow (EV/OCF)
16.75 17.30 19.26 19.45 19.85 62.32 27.24 30.24 38.64 32.36 27.70
Enterprise Value to Free Cash Flow (EV/FCFF)
26.26 21.03 0.00 1,246.36 34.98 0.00 0.00 0.00 0.00 0.00 32.26
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.69 0.52 1.01 0.87 0.89 1.35 1.41 1.53 1.52 1.26 1.05
Long-Term Debt to Equity
0.51 0.48 0.77 0.54 0.83 1.29 1.02 1.24 1.21 1.01 0.88
Financial Leverage
0.66 0.61 0.79 0.93 0.88 1.10 1.38 1.47 1.52 1.38 1.15
Leverage Ratio
2.01 2.00 2.20 2.33 2.25 2.61 3.00 3.03 2.98 2.75 2.50
Compound Leverage Factor
2.03 2.02 2.20 2.36 2.42 2.41 3.00 2.90 3.18 2.85 2.49
Debt to Total Capital
40.90% 34.32% 50.29% 46.49% 47.11% 57.38% 58.57% 60.46% 60.31% 55.76% 51.14%
Short-Term Debt to Total Capital
10.60% 2.51% 12.17% 17.77% 3.03% 2.46% 16.27% 11.38% 12.17% 10.96% 8.20%
Long-Term Debt to Total Capital
30.30% 31.81% 38.12% 28.73% 44.09% 54.92% 42.30% 49.08% 48.15% 44.81% 42.93%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.91% 1.10% 1.07% 1.07% 0.80% 0.72% 0.54% 0.18% 0.17% 1.45% 1.22%
Common Equity to Total Capital
58.19% 64.57% 48.64% 52.44% 52.08% 41.90% 40.89% 39.36% 39.52% 42.79% 47.64%
Debt to EBITDA
2.00 1.48 2.76 2.73 4.26 -32.16 4.18 3.72 4.19 4.50 3.45
Net Debt to EBITDA
1.83 1.37 2.63 2.41 3.92 -28.50 2.63 3.56 3.99 4.34 3.33
Long-Term Debt to EBITDA
1.48 1.37 2.09 1.69 3.98 -30.78 3.02 3.02 3.34 3.62 2.89
Debt to NOPAT
4.17 2.85 5.56 4.76 9.53 -11.28 8.62 7.04 9.18 11.11 8.45
Net Debt to NOPAT
3.82 2.64 5.30 4.19 8.78 -10.00 5.42 6.75 8.75 10.70 8.17
Long-Term Debt to NOPAT
3.09 2.65 4.21 2.94 8.92 -10.80 6.23 5.71 7.33 8.93 7.10
Noncontrolling Interest Sharing Ratio
1.63% 1.61% 1.93% 2.07% 1.76% 1.60% 1.48% 0.86% 0.44% 1.97% 2.87%
Liquidity Ratios
- - - - - - - - - - -
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
393 633 -1,401 13 382 -500 -1,068 -577 -246 -53 1,137
Operating Cash Flow to CapEx
0.00% 0.00% 0.00% 0.00% 208.82% 0.00% 0.00% 0.00% 0.00% 185.73% 0.00%
Free Cash Flow to Firm to Interest Expense
5.73 9.92 -15.21 0.14 3.69 -4.48 -7.54 -3.97 -1.35 -0.22 4.96
Operating Cash Flow to Interest Expense
8.98 12.05 8.94 8.79 6.49 2.81 6.68 9.17 4.14 4.63 5.78
Operating Cash Flow Less CapEx to Interest Expense
8.98 12.05 8.94 8.79 3.38 2.81 6.68 9.17 4.14 2.14 5.78
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.51 0.57 0.00 0.47 0.46 0.45 0.00 0.46 0.44 0.42 0.45
Fixed Asset Turnover
0.00 26.31 0.00 21.87 30.11 6.60 0.00 0.00 3.40 2.94 2.93
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
3,781 3,579 5,475 6,054 5,967 6,154 7,748 9,108 10,011 10,596 10,068
Invested Capital Turnover
0.62 0.71 0.00 0.57 0.55 0.56 0.00 0.57 0.52 0.49 0.53
Increase / (Decrease) in Invested Capital
-22 -202 1,896 579 -87 187 1,594 1,360 904 585 -528
Enterprise Value (EV)
10,319 13,308 15,848 15,869 13,346 19,556 25,771 40,367 29,251 36,135 36,691
Market Capitalization
8,866 12,133 13,166 13,327 10,711 16,383 22,877 35,068 23,481 30,290 31,589
Book Value per Share
$18.25 $19.51 $22.23 $26.44 $25.77 $21.30 $26.05 $29.38 $32.31 $36.80 $38.70
Tangible Book Value per Share
($14.21) ($11.78) ($25.36) ($23.15) ($24.05) ($23.70) ($31.19) ($38.25) ($35.45) ($34.49) ($27.16)
Total Capital
3,781 3,579 5,475 6,054 5,967 6,154 7,748 9,108 10,011 10,596 10,068
Total Debt
1,546 1,228 2,753 2,815 2,811 3,531 4,538 5,507 6,038 5,909 5,149
Total Long-Term Debt
1,146 1,138 2,087 1,739 2,631 3,380 3,277 4,470 4,820 4,748 4,323
Net Debt
1,418 1,135 2,624 2,478 2,588 3,130 2,853 5,282 5,753 5,692 4,979
Capital Expenditures (CapEx)
0.00 0.00 0.00 0.00 322 0.00 0.00 0.00 0.00 601 0.00
Net Nonoperating Expense (NNE)
-3.00 -4.44 0.00 -6.17 -22 65 0.00 34 -43 -20 1.87
Net Nonoperating Obligations (NNO)
1,546 1,228 2,753 2,815 2,811 3,531 4,538 5,507 6,038 5,909 5,149
Total Depreciation and Amortization (D&A)
204 200 269 291 316 337 399 490 569 620 681
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$3.03 $3.61 $4.10 $4.89 $2.49 ($3.30) $4.28 $6.11 $5.69 $4.44 $4.88
Adjusted Weighted Average Basic Shares Outstanding
121.20M 118.70M 119.30M 120.10M 120.40M 120.90M 121.50M 121.90M 122.40M 122.90M 123.80M
Adjusted Diluted Earnings per Share
$2.97 $3.55 $4.04 $4.83 $2.47 ($3.27) $4.24 $6.02 $5.65 $4.40 $4.84
Adjusted Weighted Average Diluted Shares Outstanding
123.50M 120.90M 121.10M 121.50M 121.40M 122M 122.80M 123.60M 123.30M 123.90M 124.90M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 ($3.30) $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
119.49M 118.71M 119.85M 120.12M 120.70M 121.24M 121.79M 122.08M 122.49M 123.96M 124.02M
Normalized Net Operating Profit after Tax (NOPAT)
371 430 -1,640 592 295 -313 -2,759 783 657 532 609
Normalized NOPAT Margin
15.67% 16.55% 0.00% 18.10% 8.91% -9.22% 0.00% 16.38% 13.31% 10.59% 11.17%
Pre Tax Income Margin
24.25% 24.49% 0.00% 22.84% 11.20% -12.19% 0.00% 19.86% 18.82% 14.29% 14.87%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
8.30 9.88 7.91 7.96 3.33 -4.00 4.84 6.82 4.77 2.87 3.55
NOPAT to Interest Expense
5.41 6.75 5.38 6.38 2.85 -2.80 3.72 5.37 3.59 2.20 2.66
EBIT Less CapEx to Interest Expense
8.30 9.88 7.91 7.96 0.22 -4.00 4.84 6.82 4.77 0.38 3.55
NOPAT Less CapEx to Interest Expense
5.41 6.75 5.38 6.38 -0.26 -2.80 3.72 5.37 3.59 -0.29 2.66
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
34.52% 33.16% 33.00% 32.74% 62.52% -51.65% 36.89% 26.25% 27.73% 43.03% 32.57%
Augmented Payout Ratio
115.16% 78.31% 33.00% 45.64% 62.52% -51.65% 36.89% 35.59% 27.73% 43.03% 32.57%

Quarterly Metrics And Ratios for Equifax

This table displays calculated financial ratios and metrics derived from Equifax's official financial filings.

Metric Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025
Period end date 3/31/2023 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025
Growth Metrics
- - - - - - - - - - -
Revenue Growth
-5.98% -1.43% 4.94% 10.74% 6.85% 9.25% 10.28% 7.69% 4.47% 8.06% 7.74%
EBITDA Growth
-30.56% -18.92% 0.47% 29.10% 10.53% 19.34% 7.02% 18.23% 8.35% 11.54% 9.06%
EBIT Growth
-49.50% -33.00% -6.23% 51.93% 11.64% 27.64% 3.92% 25.84% 10.85% 14.58% 11.16%
NOPAT Growth
-48.65% -36.08% 6.35% 44.81% 13.31% 29.37% -11.18% 31.51% 5.69% 14.83% 13.25%
Net Income Growth
-49.06% -30.78% -1.56% 23.28% 11.10% 18.51% -13.15% 28.85% 6.11% 16.59% 13.17%
EPS Growth
-49.44% -31.29% -2.24% 20.45% 9.89% 16.96% -13.74% 32.08% 6.00% 16.79% 14.16%
Operating Cash Flow Growth
176.02% -4.79% 7.55% -1.01% 67.46% 2.06% 25.62% 0.84% -11.40% 34.99% 16.77%
Free Cash Flow Firm Growth
96.00% 89.50% -48.18% 44.55% -448.00% -73.17% 121.25% 257.30% 210.44% 222.10% 436.97%
Invested Capital Growth
1.82% 3.42% 8.61% 5.84% 5.02% 5.18% -0.05% -4.98% -2.72% -2.29% -5.87%
Revenue Q/Q Growth
8.83% 1.00% -0.05% 0.79% 5.02% 3.27% 0.90% -1.58% 1.87% 6.82% 0.59%
EBITDA Q/Q Growth
12.78% 9.43% 3.66% 0.91% -3.44% 18.15% -7.04% 11.48% -11.50% 21.63% -9.11%
EBIT Q/Q Growth
21.65% 19.22% 4.20% 0.54% -10.62% 36.30% -15.16% 21.75% -21.27% 40.90% -17.70%
NOPAT Q/Q Growth
17.57% 16.01% 23.71% -14.18% -8.00% 32.45% -15.07% 27.07% -26.06% 43.90% -16.24%
Net Income Q/Q Growth
4.03% 22.82% 17.86% -18.14% -6.25% 31.01% -13.62% 21.44% -22.79% 43.95% -16.15%
EPS Q/Q Growth
3.41% 23.08% 16.96% -19.08% -5.66% 31.00% -13.74% 23.89% -24.29% 44.34% -15.69%
Operating Cash Flow Q/Q Growth
-53.63% 73.69% 45.63% -15.61% -21.55% 5.86% 79.25% -32.26% -31.07% 61.28% 55.05%
Free Cash Flow Firm Q/Q Growth
91.46% -195.22% -236.82% 34.71% 15.59% 6.71% 141.33% 383.29% -40.74% 3.14% 81.78%
Invested Capital Q/Q Growth
0.20% -0.03% 6.46% -0.75% -0.57% 0.12% 1.17% -5.65% 1.79% 0.56% -2.53%
Profitability Metrics
- - - - - - - - - - -
EBITDA Margin
24.11% 26.12% 27.09% 27.12% 24.94% 28.53% 26.29% 29.77% 25.87% 29.45% 26.61%
EBIT Margin
11.88% 14.02% 14.61% 14.58% 12.41% 16.38% 13.77% 17.04% 13.17% 17.37% 14.21%
Profit (Net Income) Margin
9.12% 11.09% 13.08% 10.62% 9.48% 12.03% 10.30% 12.71% 9.63% 12.98% 10.82%
Tax Burden Percent
74.57% 72.57% 86.16% 73.54% 75.69% 73.55% 73.63% 76.85% 72.17% 73.71% 75.01%
Interest Burden Percent
102.98% 109.02% 103.87% 99.08% 100.97% 99.87% 101.57% 97.07% 101.37% 101.40% 101.51%
Effective Tax Rate
25.43% 27.43% 13.84% 26.46% 24.31% 26.45% 26.37% 23.15% 27.83% 26.29% 24.99%
Return on Invested Capital (ROIC)
4.33% 4.99% 6.02% 5.23% 4.67% 6.12% 5.09% 6.91% 5.04% 6.90% 5.90%
ROIC Less NNEP Spread (ROIC-NNEP)
4.38% 5.19% 6.12% 5.21% 4.69% 6.11% 5.12% 6.81% 5.07% 6.95% 5.94%
Return on Net Nonoperating Assets (RNNOA)
6.61% 7.56% 9.07% 7.18% 6.27% 7.80% 6.35% 7.84% 5.66% 7.44% 6.22%
Return on Equity (ROE)
10.93% 12.56% 15.09% 12.41% 10.94% 13.92% 11.44% 14.75% 10.70% 14.35% 12.11%
Cash Return on Invested Capital (CROIC)
3.76% 1.51% -3.48% -0.51% 0.41% 0.64% 5.36% 11.01% 8.69% 8.46% 12.41%
Operating Return on Assets (OROA)
5.02% 5.96% 6.06% 6.15% 5.32% 7.23% 5.97% 7.73% 6.02% 8.11% 6.73%
Return on Assets (ROA)
3.86% 4.72% 5.42% 4.48% 4.07% 5.31% 4.47% 5.76% 4.40% 6.06% 5.13%
Return on Common Equity (ROCE)
10.89% 12.50% 14.71% 12.17% 10.73% 13.68% 11.04% 14.33% 10.39% 13.96% 11.78%
Return on Equity Simple (ROE_SIMPLE)
14.54% 12.62% 12.26% 0.00% 12.37% 12.57% 11.58% 0.00% 12.35% 12.59% 13.39%
Net Operating Profit after Tax (NOPAT)
110 128 158 136 125 165 140 179 132 190 159
NOPAT Margin
8.86% 10.17% 12.59% 10.72% 9.39% 12.05% 10.14% 13.09% 9.50% 12.80% 10.66%
Net Nonoperating Expense Percent (NNEP)
-0.05% -0.20% -0.10% 0.02% -0.02% 0.00% -0.04% 0.09% -0.03% -0.05% -0.05%
SG&A Expenses to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
88.12% 85.98% 85.39% 85.42% 87.59% 83.62% 86.23% 82.96% 86.83% 82.63% 85.79%
Earnings before Interest and Taxes (EBIT)
148 176 184 185 165 225 191 232 183 258 212
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
300 328 340 343 332 392 364 406 359 437 397
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
6.06 6.84 5.20 6.68 7.21 6.38 7.41 6.59 6.06 6.31 6.43
Price to Tangible Book Value (P/TBV)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Price to Revenue (P/Rev)
5.07 5.92 4.56 6.03 6.44 5.74 6.79 5.79 5.48 5.73 5.54
Price to Earnings (P/E)
41.97 54.64 42.88 55.55 59.00 51.37 64.64 52.29 49.33 50.36 48.22
Dividend Yield
0.78% 0.67% 0.86% 0.63% 0.58% 0.64% 0.53% 0.61% 0.64% 0.64% 0.69%
Earnings Yield
2.38% 1.83% 2.33% 1.80% 1.69% 1.95% 1.55% 1.91% 2.03% 1.99% 2.07%
Enterprise Value to Invested Capital (EV/IC)
3.03 3.42 2.65 3.41 3.67 3.38 3.90 3.64 3.44 3.61 3.65
Enterprise Value to Revenue (EV/Rev)
6.25 7.09 5.78 7.19 7.57 6.82 7.78 6.73 6.40 6.62 6.40
Enterprise Value to EBITDA (EV/EBITDA)
23.19 27.85 22.93 27.54 28.79 25.33 29.11 24.57 23.19 23.76 22.93
Enterprise Value to EBIT (EV/EBIT)
41.70 53.54 45.00 52.20 54.53 47.01 54.43 45.13 42.46 43.10 41.44
Enterprise Value to NOPAT (EV/NOPAT)
54.92 71.40 57.84 67.93 70.76 60.93 73.52 60.23 57.26 58.10 55.62
Enterprise Value to Operating Cash Flow (EV/OCF)
27.44 31.40 25.27 32.36 31.74 29.12 31.51 27.70 27.23 26.80 24.95
Enterprise Value to Free Cash Flow (EV/FCFF)
81.29 230.83 0.00 0.00 906.91 541.40 72.79 32.26 39.07 42.18 28.54
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
1.46 1.38 1.38 1.26 1.24 1.18 1.11 1.05 1.00 0.97 0.98
Long-Term Debt to Equity
1.22 1.31 1.23 1.01 1.01 0.98 0.94 0.88 0.85 0.77 0.80
Financial Leverage
1.51 1.46 1.48 1.38 1.34 1.28 1.24 1.15 1.12 1.07 1.05
Leverage Ratio
2.90 2.83 2.86 2.75 2.71 2.62 2.59 2.50 2.45 2.39 2.39
Compound Leverage Factor
2.98 3.09 2.97 2.73 2.74 2.62 2.63 2.43 2.49 2.42 2.42
Debt to Total Capital
59.31% 58.04% 58.00% 55.76% 55.27% 54.17% 52.71% 51.14% 50.12% 49.20% 49.47%
Short-Term Debt to Total Capital
9.58% 3.16% 6.48% 10.96% 10.23% 9.21% 8.47% 8.20% 7.92% 9.89% 9.11%
Long-Term Debt to Total Capital
49.72% 54.87% 51.52% 44.81% 45.04% 44.96% 44.24% 42.93% 42.19% 39.31% 40.36%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.18% 0.17% 1.79% 1.45% 1.43% 1.30% 1.29% 1.22% 1.28% 1.28% 1.37%
Common Equity to Total Capital
40.51% 41.79% 40.21% 42.79% 43.30% 44.52% 46.00% 47.64% 48.60% 49.53% 49.16%
Debt to EBITDA
4.54 4.72 5.02 4.50 4.33 4.06 3.93 3.45 3.38 3.24 3.11
Net Debt to EBITDA
4.37 4.59 4.68 4.34 4.18 3.93 3.60 3.33 3.25 3.12 2.99
Long-Term Debt to EBITDA
3.81 4.46 4.46 3.62 3.53 3.37 3.30 2.89 2.84 2.59 2.53
Debt to NOPAT
10.76 12.10 12.65 11.11 10.65 9.77 9.93 8.45 8.34 7.91 7.54
Net Debt to NOPAT
10.34 11.76 11.81 10.70 10.29 9.46 9.10 8.17 8.02 7.62 7.25
Long-Term Debt to NOPAT
9.02 11.44 11.24 8.93 8.68 8.11 8.33 7.10 7.02 6.32 6.15
Noncontrolling Interest Sharing Ratio
0.44% 0.41% 2.52% 1.97% 1.91% 1.71% 3.45% 2.87% 2.86% 2.67% 2.72%
Liquidity Ratios
- - - - - - - - - - -
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
-69 -204 -688 -449 -379 -354 146 707 419 432 785
Operating Cash Flow to CapEx
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Free Cash Flow to Firm to Interest Expense
-1.20 -3.36 -10.95 -7.45 -6.35 -6.17 2.60 12.66 7.91 8.13 15.04
Operating Cash Flow to Interest Expense
2.62 4.32 6.08 5.34 4.23 4.67 8.52 5.82 4.23 6.80 10.73
Operating Cash Flow Less CapEx to Interest Expense
2.62 4.32 6.08 5.34 4.23 4.67 8.52 5.82 4.23 6.80 10.73
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.42 0.43 0.41 0.42 0.43 0.44 0.43 0.45 0.46 0.47 0.47
Fixed Asset Turnover
0.00 0.00 0.00 2.94 0.00 0.00 0.00 2.93 0.00 0.00 0.00
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
10,032 10,029 10,677 10,596 10,536 10,548 10,671 10,068 10,249 10,306 10,045
Invested Capital Turnover
0.49 0.49 0.48 0.49 0.50 0.51 0.50 0.53 0.53 0.54 0.55
Increase / (Decrease) in Invested Capital
179 332 846 585 504 519 -5.70 -528 -287 -242 -626
Enterprise Value (EV)
30,364 34,334 28,310 36,135 38,683 35,641 41,655 36,691 35,280 37,227 36,675
Market Capitalization
24,629 28,660 22,339 30,290 32,910 29,971 36,361 31,589 30,207 32,214 31,758
Book Value per Share
$33.18 $34.17 $34.98 $36.80 $36.94 $37.99 $39.67 $38.70 $40.16 $41.10 $39.89
Tangible Book Value per Share
($52.35) ($51.82) ($55.94) ($34.49) ($53.96) ($52.86) ($51.22) ($27.16) ($48.71) ($48.32) ($50.02)
Total Capital
10,032 10,029 10,677 10,596 10,536 10,548 10,671 10,068 10,249 10,306 10,045
Total Debt
5,949 5,820 6,192 5,909 5,823 5,714 5,624 5,149 5,136 5,070 4,969
Total Long-Term Debt
4,988 5,503 5,500 4,748 4,745 4,743 4,721 4,323 4,324 4,051 4,054
Net Debt
5,717 5,656 5,780 5,692 5,622 5,532 5,156 4,979 4,941 4,881 4,780
Capital Expenditures (CapEx)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Nonoperating Expense (NNE)
-3.28 -12 -6.12 1.25 -1.21 0.22 -2.21 5.23 -1.80 -2.65 -2.40
Net Nonoperating Obligations (NNO)
5,949 5,820 6,192 5,909 5,823 5,714 5,624 5,149 5,136 5,070 4,969
Total Depreciation and Amortization (D&A)
152 152 157 159 167 167 173 174 176 179 185
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$0.92 $1.13 $1.32 $1.07 $1.01 $1.32 $1.14 $1.41 $1.07 $1.54 $1.30
Adjusted Weighted Average Basic Shares Outstanding
122.60M 122.70M 123M 122.90M 123.50M 123.70M 123.90M 123.80M 124.10M 124M 123.10M
Adjusted Diluted Earnings per Share
$0.91 $1.12 $1.31 $1.06 $1.00 $1.31 $1.13 $1.40 $1.06 $1.53 $1.29
Adjusted Weighted Average Diluted Shares Outstanding
123.50M 123.80M 123.90M 123.90M 124.80M 124.80M 125.20M 124.90M 125.10M 125M 124.10M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
122.64M 122.72M 123.22M 123.96M 123.61M 123.74M 123.95M 124.02M 124.20M 123.80M 122.39M
Normalized Net Operating Profit after Tax (NOPAT)
110 128 158 136 125 165 140 179 132 190 159
Normalized NOPAT Margin
8.86% 10.17% 12.59% 10.72% 9.39% 12.05% 10.14% 13.09% 9.50% 12.80% 10.66%
Pre Tax Income Margin
12.23% 15.28% 15.18% 14.44% 12.53% 16.36% 13.99% 16.54% 13.35% 17.61% 14.42%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
2.57 2.90 2.92 3.06 2.76 3.93 3.39 4.16 3.46 4.85 4.06
NOPAT to Interest Expense
1.91 2.11 2.52 2.25 2.09 2.89 2.50 3.20 2.50 3.58 3.05
EBIT Less CapEx to Interest Expense
2.57 2.90 2.92 3.06 2.76 3.93 3.39 4.16 3.46 4.85 4.06
NOPAT Less CapEx to Interest Expense
1.91 2.11 2.52 2.25 2.09 2.89 2.50 3.20 2.50 3.58 3.05
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
32.78% 36.64% 37.03% 43.03% 42.19% 40.59% 42.23% 32.57% 32.15% 33.11% 34.30%
Augmented Payout Ratio
32.78% 36.64% 37.03% 43.03% 42.19% 40.59% 42.23% 32.57% 32.15% 33.11% 34.30%

Financials Breakdown Chart

Key Financial Trends

Equifax Inc. (NYSE: EFX) has demonstrated consistent financial performance across the last four years, with notable trends apparent in its income, cash flow, and balance sheets.

Key Positive Trends:

  • Steady increase in net income: Net income has grown from approximately $108 million in Q4 2022 to $161.5 million in Q3 2025, indicating ongoing profitability improvement.
  • Consistent cash flow from operating activities: Quarterly operating cash flow increased from around $252 million in Q1 2025 to about $560 million by Q3 2025, signaling strong operational efficiency and cash-generating ability.
  • Strong common equity base accumulation: Total common equity rose from about $3.96 billion in Q4 2022 to roughly $4.94 billion by Q3 2025, showing improved shareholder value and financial strength.
  • Dividends have been steadily maintained at around $0.39 to $0.50 per share per quarter, underscoring a commitment to returning profits to shareholders.
  • Goodwill and intangible assets remain significant, reflecting substantial investments in long-term assets that could fuel future growth.
  • Depreciation expenses have increased moderately, consistent with expanding asset base and possibly updated accounting for asset usage, supporting long-term operational capacity.

Neutral Observations:

  • Interest expense on long-term debt remains substantial (around $50-60 million quarterly), reflecting ongoing financing costs typical for a company of this size.
  • Total liabilities have fluctuated but remained sizable (~$6.7 to $7.5 billion), which is a normal aspect of Equifax's capital structure leveraging for growth and operations.
  • Short-term debt levels exhibit some volatility but stay within the $700 million to $900 million range, manageable given the company’s liquidity position.

Key Negative Trends:

  • Repurchase of common equity is notable, with $300 million spent in Q3 2025 alone, which could reduce liquidity and raise concerns about capital allocation if not balanced with growth.
  • Investing activities are consistently showing negative cash flows (e.g., -$122 million in Q3 2025), reflecting ongoing capital expenditures and investment securities purchases, which, while normal, may pressure free cash flow if not translating to higher returns.
  • Total liabilities have remained relatively high compared to equity, posing leverage and interest burden considerations.
  • Net interest expense has a negative impact on profitability, as reflected by a roughly $52 million quarterly cost, potentially limiting net income growth.
  • Accumulated other comprehensive loss remains significant (in the range of -$500 million), which may indicate exposure to foreign currency or other valuation risks impacting equity.

Overall, Equifax's financials indicate solid earnings growth and strong operational cash flows boosting shareholder equity. However, the company’s considerable liabilities, consistent investing outflows, and significant equity repurchases warrant monitoring, particularly regarding their impact on liquidity and long-term financial flexibility.

10/24/25 05:37 AM ETAI Generated. May Contain Errors.

Frequently Asked Questions About Equifax's Financials

When does Equifax's fiscal year end?

According to the most recent income statement we have on file, Equifax's financial year ends in December. Their financial year 2024 ended on December 31, 2024.

How has Equifax's net income changed over the last 10 years?

Equifax's net income appears to be on an upward trend, with a most recent value of $607.30 million in 2024, rising from $374 million in 2014. The previous period was $551.70 million in 2023. See Equifax's forecast for analyst expectations on what’s next for the company.

How has Equifax's revenue changed over the last 10 years?

Over the last 10 years, Equifax's total revenue changed from $2.37 billion in 2014 to $5.45 billion in 2024, a change of 130.3%.

How much debt does Equifax have?

Equifax's total liabilities were at $6.84 billion at the end of 2024, a 9.9% decrease from 2023, and a 181.9% increase since 2014.

How much cash does Equifax have?

In the past 10 years, Equifax's cash and equivalents has ranged from $93.30 million in 2015 to $1.68 billion in 2020, and is currently $169.90 million as of their latest financial filing in 2024.

How has Equifax's book value per share changed over the last 10 years?

Over the last 10 years, Equifax's book value per share changed from 18.25 in 2014 to 38.70 in 2024, a change of 112.1%.



This page (NYSE:EFX) was last updated on 10/24/2025 by MarketBeat.com Staff
From Our Partners